CA
NZ
UK
AU
IND
US
Shattuck Labs, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the Securities and Exchange Commission, with the report made available on August 11, 2026.
Twenty One Capital, Inc. filed its quarterly report on Form 10-Q with the SEC for the quarterly period ended June 30, 2026, disclosing condensed consolidated financial statements and related information as of that date.
Twenty One Capital, Inc. filed a Form 8-K with the SEC on August 11, 2026, disclosing that Chief Executive Officer Raphael Zagury issued a letter to shareholders on the same date, furnished under Regulation FD.
Upstream Bio, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 11, 2026, covering the fiscal quarter ended June 30, 2026.
Kardigan, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 11, 2026, covering the fiscal quarter ended June 30, 2026.
Tango Therapeutics, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 11, 2026, covering the fiscal quarter ended June 30, 2026.
Aura Biosciences, Inc. filed a Form 8-K on August 11, 2026, disclosing an organizational realignment, a planned workforce reduction of approximately 20%, the appointment of Susan Abu-Absi, Ph.D. as Chief Operating Officer, and the announcement of financial results for the quarter ended June 30, …
908 Devices Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, disclosing condensed consolidated balance sheet data and related financial statements.
C4 Therapeutics, Inc. (NASDAQ:CCCC) filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 11, 2026.
Sagimet Biosciences Inc. filed a current report on Form 8-K with the SEC on August 11, 2026, disclosing its financial results for the quarter ended June 30, 2026, and furnishing an updated investor presentation.
Please wait processing your request...